• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Coronary CTA exposes plaque risk for diabetics

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 12
Volume 31
Issue 12

Findings from a large multicenter study suggest 64-slice CT angiography is better suited than other cardiac diagnostic tests for detecting clinically relevant coronary artery plaques in patients with diabetes.

Findings from a large multicenter study suggest 64-slice CT angiography is better suited than other cardiac diagnostic tests for detecting clinically relevant coronary artery plaques in patients with diabetes.

Dr. Fay Y. Lin, an associate professor of medicine at Cornell University, and colleagues prospectively evaluated a cohort of 3926 patients with symptomatic cardiovascular disease, Lin determined that 727 had diabetes. All patients underwent coronary 64-slice CTA between 2005 and 2007. Researchers found that patients with diabetes faced twice the risk of dying from a cardiac-related problem within two years of diagnosis as nondiabetic patients. CTA more accurately characterized plaque burden than alternative modalities for patients with low calcium score or normal stress testing results. Lin reported the findings at the 2009 Society of Cardiovascular Computed Tomography meeting.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.